TTKHLTCARE
TTK HEALTHCARE LIMITED
Each stock's 10,000-path forecast, rendered as light.
TTK HEALTHCARE LIMITED (TTKHLTCARE) Stock Analysis & Case Study
Is TTKHLTCARE a good buy? The data-driven verdict.
TTK HEALTHCARE LIMITED (TTKHLTCARE) trades at ₹1,085,on the numbers it mixed signals, a Downstox Snapshot Score of 49/100.
On the numbers, TTK HEALTHCARE LIMITED (TTKHLTCARE) mixed signals, a Downstox Snapshot Score of 49/100, weighing fairly valued at 20.0× earnings, ROE of 6.3%, a 58% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
TTKHLTCARE fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How TTKHLTCARE ranks against the 2,373 companies in our screener
- TTKHLTCARE's market cap of 1,533 Cr ranks in the 46th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TTKHLTCARE's book value of ₹789 ranks in the top 5% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TTKHLTCARE's promoter holding of 74.6% ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TTKHLTCARE's 3-year profit (PAT) growth of -52.0% ranks in the bottom 2% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TTKHLTCARE's 3-year revenue growth of 6.0% ranks in the 38th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TTKHLTCARE's debt-to-equity ratio of 0.02x is lower than 94% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is TTKHLTCARE overvalued? TTKHLTCARE P/E vs peers
TTKHLTCARE trades at 20.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
TTKHLTCARE share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of TTKHLTCARE history (1%/yr drift, 29%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| TTKHLTCARE 2027 | ₹799 | ₹1,151 | ₹1,658 | +6% |
| TTKHLTCARE 2028 | ₹726 | ₹1,221 | ₹2,054 | +13% |
| TTKHLTCARE 2029 | ₹674 | ₹1,295 | ₹2,486 | +19% |
| TTKHLTCARE 2030 | ₹653 | ₹1,374 | ₹2,887 | +27% |
| TTKHLTCARE 2031 | ₹636 | ₹1,457 | ₹3,335 | +34% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability TTKHLTCARE goes up, or doubles?
The bull case for TTKHLTCARE
- TTKHLTCARE's P/E of 20.0x is lower than 63% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Low price-to-book of 1.38×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹2,486.
The bear case & risks
- TTKHLTCARE's return on equity of 6.3% ranks in the 34th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹674.
TTKHLTCARE volatility & expected range, how bumpy is the ride?
Over the last 9.8 years TTKHLTCARE compounded at 1%/year with annualized volatility of 29%. That volatility implies a 1-year 80% range of ₹799-₹1,658, the honest backbone behind any single price target.
TTKHLTCARE price forecast, the full 60-month probability fan
TTKHLTCARE price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds TTKHLTCARE hits common targets within the simulated horizon?
Full multi-horizon detail on the TTKHLTCARE price target & forecast page.
TTKHLTCARE Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. TTKHLTCARE scores 5/8, mixed financial health.
TTKHLTCARE MTF margin & leverage across 6 brokers
Margin Trading Facility lets you buy TTKHLTCARE with part of the capital. Lower margin % = higher leverage. Rates compared across 6 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Zerodha | 50.00% | 2.0× |
| Dhan | 50.00% | 2.0× |
| Kotak Neo | 100.00% | 1.0× |
| Anand Rathi | 29.39% | 3.4× |
| Bajaj Broking | 45.00% | 2.2× |
| Share IndiaCHEAPEST | 29.31% | 3.4× |
Compare every broker on the TTKHLTCARE MTF page.
About TTK HEALTHCARE LIMITED: sector, index & market-cap context
TTK HEALTHCARE LIMITED (TTKHLTCARE) is a small-cap NSE-listed company, with a market capitalisation of ₹1,533 Cr. See more stocks on our screener.
How the TTKHLTCARE Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of TTK HEALTHCARE LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
TTKHLTCARE analysis, FAQs
Is TTK HEALTHCARE LIMITED (TTKHLTCARE) a good buy?
On the numbers, TTK HEALTHCARE LIMITED (TTKHLTCARE) mixed signals, a Downstox Snapshot Score of 49/100, weighing fairly valued at 20.0× earnings, ROE of 6.3%, a 58% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is TTKHLTCARE overvalued or undervalued?
TTKHLTCARE trades at 20.0× earnings, fairly valued versus the ~22× long-run Nifty average.
What is the TTKHLTCARE share price target for 2031?
TTKHLTCARE's probability-weighted 2031 median target is ₹1,457, with an 80% range of ₹636-₹3,335 (10,000-path Monte-Carlo).
What is the probability TTKHLTCARE doubles in 5 years?
The modelled probability of TTKHLTCARE reaching ₹2,170 (2×) within 5 years is 27%.
What is the bull case for TTKHLTCARE?
TTKHLTCARE's P/E of 20.0x is lower than 63% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. Low price-to-book of 1.38×, the market is paying little over the company's net assets.
What are the risks in TTKHLTCARE?
TTKHLTCARE's return on equity of 6.3% ranks in the 34th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.